Dapagliflozin modulates hepatic lipid metabolism through the proprotein convertase subtilisin/kexin type 9/low density lipoprotein receptor pathway

Fengyuan Lu(Second Affiliated Hospital of Zhengzhou University), Xiaoyu Yang(Huazhong University of Science and Technology), Lijuan Kong(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Zhang(First Affiliated Hospital of Xi'an Jiaotong University), En Li(Chongqing University), Yifeng Gao(German Cancer Research Center)
Diabetes Obesity and Metabolism
January 20, 2025
Cited by 3


Related Papers